Mazor Robotics Ltd. (tase:MZOR), innovator of surgical robots and complementary products for spine surgery, announced a purchase agreement with NSH Michigan Inc. The Renaissance system will be installed at NSH Michigan Inc.'s affiliate, the Lakes Surgery Center, in West Bloomfield, Mich. The Renaissance system was recently launched as the new generation of Mazor Robotics Guidance Systems.
With the Renaissance system already in use at leading U.S. hospitals specializing in spine surgery, this is the first Renaissance system installed in an ambulatory surgery center. According to National Health Statistic Reports, more than 300,000 people in the U.S. seek surgery annually for relief from chronic back pain resulting from spinal disc diseases, including herniations and protrusions. Common spine procedures such as endoscopic discectomy are typically performed in spine surgery centers while other procedures such as spinal fusion are usually performed in hospitals. With new technology such as the Renaissance system, more cases can be performed on an outpatient basis with minimal recovery time.
"Our clinical experiences with Mazor Robotics' technology, including examination of numerous peer-reviewed studies and hands-on demonstrations, has convinced us to add Renaissance to our surgical program," says Jennifer Butterfield, CEO of Lakes Surgery Center. "We believe that Mazor Robotics' Renaissance system will differentiate our facility by enabling us to raise the level of patient care, for spinal endoscopy as well as for other spine procedures."
Dr. Kevin Lee, a leading neurosurgeon and pain management/spinal endoscopy specialist at Lakes Surgery Center, adds, "Many of my spine surgery referrals are for spinal endoscopy procedures. Demand for minimally invasive surgery has grown dramatically in recent years, and as technology advances we see improvement in patient outcomes. We recognize the tremendous potential of Renaissance; it is the next step in the evolution of incorporating state-of-the-art technology for better patient care. Mazor Robotics' technology will take these procedures to the next level by providing a safer and more accurate way to enter the surgical site, reduce intra-operative radiation, shorten procedure time, and reduce complications."
Mazor Robotics' CEO Ori Hadomi acknowledges that the purchase agreement with NSH Michigan Inc. is a strategically important one, significantly expanding the company's market opportunity among American ASCs. He adds, "We are also excited about the clinical opportunity this represents, as many more patients will now have access to such minimally invasive procedures."
According to the company, Mazor Robotics systems have been successfully used in the placement of more than 15,000 implants in the U.S. and Europe.
